Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease



Rating:

Share or cite this content

Citations should be made in the following way:
J. Jacob (London, United Kingdom). Novel imaging biomarkers for assessment of lung fibrosis and inflammation. Virtual Congress 2021 – Emerging imaging biomarkers in lung disease

Member's Comments

No comment yet.

Related content which might interest you: Oxygen enhanced MRI biomarkers of lung function in interstitial lung disease Source: Virtual Congress 2020 – Quantitative imaging in diffuse lung disease Year: 2020 Preclinical models and imaging biomarkers of lung injury and disease Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease Year: 2021 Metabolomic biomarkers predictive of early structural lung disease in cystic fibrosis Source: Eur Respir J 2016; 48: 1612-1621 Year: 2016 Biological- and imaging biomarkers of edema and fibrosis in a rat model of drug-induced interstitial lung disease (DIILD) Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019 The use of non-invasive inflammatory markers to predict presence, severity and stability of cystic fibrosis lung disease Source: Eur Respir J 2006; 28: Suppl. 50, 327s Year: 2006 Interstitial pulmonary fibrosis model develpment and identification of early biomarkers by MALDI imaging Source: International Congress 2015 – New insights into IIPs Year: 2015 Quantitative assessment of lung pathology in interstitial lung diseases Source: Eur Respir J 2001; 18: Suppl. 33, 243s Year: 2001 Role of imaging in progressive-fibrosing interstitial lung diseases Source: Eur Respir Rev, 27 (150) 180073; 10.1183/16000617.0073-2018 Year: 2018 Longitudinal micro-CT-derived biomarkers: the new standard readouts for preclinical evaluation of pulmonary fibrosis and therapy Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues Year: 2019 Identifying serum molecular biomarkers that distinguish emphysema and early fibrotic interstitial lung disease. Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia Year: 2021 Use of MRI for functional and structural assessment of interstitial lung disease Source: International Congress 2018 – Emerging and novel imaging biomarkers in drug-induced interstitial lung disease Year: 2018 Lung functions and imaging characteristics of the patients with combined pulmonary fibrosis and emphysema Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Longitudinal imaging characterisation of a model of chronic allergic lung inflammation in mice Source: Annual Congress 2012 - Functional imaging in pulmonary oncology and COPD. Radiation dose in chest CT: survey and real life Year: 2012 Use of PET/CT to evaluate pulmonary inflammation and fibrosis in an animal model Source: Eur Respir J 2006; 28: Suppl. 50, 606s Year: 2006 Non-invasive molecular imaging of pulmonary fibrosis Source: International Congress 2018 – Emerging and novel imaging biomarkers in drug-induced interstitial lung disease Year: 2018 Imaging biomarkers of oedema and fibrosis in a rat model of Drug-Induced-ILD Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers Year: 2018 Importance of serial changes in biomarkers in idiopathic pulmonary fibrosis Source: ERJ Open Res, 3 (3) 00019-2016; 10.1183/23120541.00019-2016 Year: 2017 Potential new biomarkers for idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 Fibulin-1 is a novel biomarker of disease severity in pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Novel biomarkers in bleomycin-induced pulmonary fibrosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013